2,277 reports of this reaction
1.6% of all DROSPIRENONE AND ETHINYL ESTRADIOL reports
#14 most reported adverse reaction
ANHEDONIA is the #14 most commonly reported adverse reaction for DROSPIRENONE AND ETHINYL ESTRADIOL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 2,277 FDA adverse event reports linking DROSPIRENONE AND ETHINYL ESTRADIOL to ANHEDONIA. This represents approximately 1.6% of all 140,358 adverse event reports for this drug.
Patients taking DROSPIRENONE AND ETHINYL ESTRADIOL who experience anhedonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANHEDONIA is a less commonly reported adverse event for DROSPIRENONE AND ETHINYL ESTRADIOL, but still significant enough to appear in the safety profile.
In addition to anhedonia, the following adverse reactions have been reported for DROSPIRENONE AND ETHINYL ESTRADIOL:
The following drugs have also been linked to anhedonia in FDA adverse event reports:
ANHEDONIA has been reported as an adverse event in 2,277 FDA reports for DROSPIRENONE AND ETHINYL ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANHEDONIA accounts for approximately 1.6% of all adverse event reports for DROSPIRENONE AND ETHINYL ESTRADIOL, making it a notable side effect.
If you experience anhedonia while taking DROSPIRENONE AND ETHINYL ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.